Publication | Closed Access

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

Hematological MalignancyChromatin StructureEpigenetic RegulationNatural SciencesMedicineImmunologyHematologyMyeloid NeoplasiaEarly ReductionInterferon αGene ExpressionMolecular DiagnosticsCell BiologyCytogenetic Response